TipRanks
Vivesto AB (SE:VIVE)
:VIVE
Sweden Market
VIVE
Vivesto AB
RESEARCH TOOLSreports
Want to see SE:VIVE full AI Analyst Report?

Vivesto AB (VIVE) Stock News & Sentiment

0 Followers
Vivesto’s Paccal Vet Data Spotlighted at Key Veterinary Oncology Conference
Premium
Company Announcements
Vivesto’s Paccal Vet Data Spotlighted at Key Veterinary Oncology Conference
14d ago
Vivesto’s Paccal Vet Shows Promising Efficacy and Safety in Feline Cancer Study
Premium
Company Announcements
Vivesto’s Paccal Vet Shows Promising Efficacy and Safety in Feline Cancer Study
21d ago
Vivesto’s Paccal Vet Shows Survival Benefit in Canine Hemangiosarcoma Study
Premium
Company Announcements
Vivesto’s Paccal Vet Shows Survival Benefit in Canine Hemangiosarcoma Study
23d ago
Vivesto Sets Maximum Tolerated Dose in Feline Paccal Vet Cancer Study
Premium
Company Announcements
Vivesto Sets Maximum Tolerated Dose in Feline Paccal Vet Cancer Study
3M ago
Vivesto completes dog cancer trial recruitment as Paccal Vet nears key data readout
Premium
Company Announcements
Vivesto completes dog cancer trial recruitment as Paccal Vet nears key data readout
3M ago
Vivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data
Premium
Company Announcements
Vivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data
3M ago
Vivesto’s Cantrixil Clears Key Preclinical Hurdle With Positive i.v. Safety Data
Premium
Company Announcements
Vivesto’s Cantrixil Clears Key Preclinical Hurdle With Positive i.v. Safety Data
4M ago
More SE:VIVE News >

VIVE News on the Web

Vivesto’s Paccal Vet Data Spotlighted at Key Veterinary Oncology Conference
TipRanks News
Bullish
Vivesto’s Paccal Vet Shows Promising Efficacy and Safety in Feline Cancer Study
TipRanks News
Bullish
Vivesto’s Paccal Vet Shows Survival Benefit in Canine Hemangiosarcoma Study
TipRanks News
Bullish
Vivesto Sets Maximum Tolerated Dose in Feline Paccal Vet Cancer Study
TipRanks News
Bullish
Vivesto completes dog cancer trial recruitment as Paccal Vet nears key data readout
TipRanks News
Bullish
Vivesto completes dog enrollment in Paccal Vet hemangiosarcoma study ahead of Q3 data
TipRanks News
Bullish
Vivesto names seasoned life science financier Björn Svanström as new CFO
TipRanks News
Bullish
Vivesto Calls 2026 AGM With Reverse Share Split on Agenda
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:VIVE’s Media Buzz Sentiment?
Currently, no data Available
What is SE:VIVE’s weekly average amount of articles?
In an average week, 0.75 articles about SE:VIVE are published.
    What is SE:VIVE’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    XENEXenon
    ABTAbbott Laboratories
    BBIOBridgeBio Pharma
    BDXBecton Dickinson
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week